HK1036221A1 - Topical composition containing human epidermal growth factor. - Google Patents

Topical composition containing human epidermal growth factor.

Info

Publication number
HK1036221A1
HK1036221A1 HK01106872A HK01106872A HK1036221A1 HK 1036221 A1 HK1036221 A1 HK 1036221A1 HK 01106872 A HK01106872 A HK 01106872A HK 01106872 A HK01106872 A HK 01106872A HK 1036221 A1 HK1036221 A1 HK 1036221A1
Authority
HK
Hong Kong
Prior art keywords
growth factor
composition containing
epidermal growth
human epidermal
containing human
Prior art date
Application number
HK01106872A
Other languages
English (en)
Inventor
Seung Yeob Lee
Jin Seok Kang
Jeom Soon Shim
Seung Wook Lim
Seung Hee Han
Byoung Kwamg Lee
Young Hyo Yu
Jong Keun Chung
Original Assignee
Dae Woong Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dae Woong Pharma filed Critical Dae Woong Pharma
Publication of HK1036221A1 publication Critical patent/HK1036221A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1808Epidermal growth factor [EGF] urogastrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK01106872A 1998-03-07 2001-09-28 Topical composition containing human epidermal growth factor. HK1036221A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR1998/000043 WO1999044631A1 (en) 1998-03-07 1998-03-07 Topical composition containing human epidermal growth factor

Publications (1)

Publication Number Publication Date
HK1036221A1 true HK1036221A1 (en) 2001-12-28

Family

ID=19530982

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01106872A HK1036221A1 (en) 1998-03-07 2001-09-28 Topical composition containing human epidermal growth factor.

Country Status (13)

Country Link
US (1) US6491904B1 (de)
EP (1) EP1061942B1 (de)
JP (1) JP3624158B2 (de)
CN (1) CN1171635C (de)
AT (1) ATE253374T1 (de)
AU (1) AU6636098A (de)
BR (1) BR9815708B1 (de)
CA (1) CA2321829C (de)
DE (1) DE69819563T2 (de)
ES (1) ES2210727T3 (de)
HK (1) HK1036221A1 (de)
RU (1) RU2202362C2 (de)
WO (1) WO1999044631A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100374110C (zh) 1998-04-21 2008-03-12 瑞克尔科感染公司 含有泊洛沙姆和其它杀微生物剂的局部制剂,以及施用器
US7465295B2 (en) 2000-10-20 2008-12-16 Bergeron Michel G Applicator for the delivery of topical formulations into mucosal cavities
WO2004002452A1 (ja) * 2002-06-27 2004-01-08 Pola Chemical Industries Inc. 医薬組成物
JP4607010B2 (ja) * 2003-02-28 2011-01-05 中外製薬株式会社 タンパク質含有安定化製剤
CN1330371C (zh) * 2004-01-15 2007-08-08 方昌阁 一种重组人表皮生长因子复合生物制剂及其应用
US8481049B2 (en) 2005-05-27 2013-07-09 Bharat Biotech International Limited Methods for treating a wound using epidermal growth factor formulation
BRPI0719509A2 (pt) * 2006-09-28 2013-12-31 Follica Inc Métodos, kits e composições para geração de novos folículos pilosos e crescimento de cabelos
EP2919805B1 (de) 2012-11-14 2022-01-05 Smith & Nephew, Inc. Stabiles thermolysin hydrogel
KR20150127280A (ko) 2013-03-15 2015-11-16 스미스 앤드 네퓨, 인크. 활성제의 전달을 위한 용해가능한 겔-형성 필름
MX2016016339A (es) * 2016-12-09 2018-06-08 Desarrolladora Y Com De Tecnologias Biomedicas Decotecbio S A S De C V Composicion coadyuvante de un factor de crecimiento y un neuropeptido para acelerar la cicatrizacion de heridas y la repitelizacion de organos.
CN106619489A (zh) * 2016-12-27 2017-05-10 西安惠普生物科技有限公司 一种用于皮肤损伤的温敏型凝胶剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57108197A (en) * 1980-12-25 1982-07-06 Nippon Catalytic Chem Ind Surfactant aqueous solution composition
US5705485A (en) * 1987-09-18 1998-01-06 Ethicon, Inc. Gel formulations containing growth factors
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
IT1255460B (it) 1992-07-28 1995-11-02 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive
JPH07108197A (ja) 1993-10-13 1995-04-25 Honda Motor Co Ltd 塗料循環型塗装装置

Also Published As

Publication number Publication date
ES2210727T3 (es) 2004-07-01
CN1171635C (zh) 2004-10-20
CA2321829A1 (en) 1999-09-10
ATE253374T1 (de) 2003-11-15
DE69819563D1 (de) 2003-12-11
DE69819563T2 (de) 2004-09-16
JP3624158B2 (ja) 2005-03-02
WO1999044631A1 (en) 1999-09-10
RU2202362C2 (ru) 2003-04-20
CN1290172A (zh) 2001-04-04
BR9815708A (pt) 2000-11-14
AU6636098A (en) 1999-09-20
BR9815708B1 (pt) 2010-10-19
US6491904B1 (en) 2002-12-10
JP2002505299A (ja) 2002-02-19
EP1061942A1 (de) 2000-12-27
CA2321829C (en) 2003-05-27
EP1061942B1 (de) 2003-11-05

Similar Documents

Publication Publication Date Title
BR0009893A (pt) Composição de cuidado com a pele; e uso de uma composição de cuidado com a pele
MY129356A (en) Electrospun pharmaceutical compositions
WO2002074274A3 (en) Oral care kits and compositions
MY134568A (en) Cb2 receptor agonists
WO2002074276A3 (en) Denture care compositions and kits
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
CA2311696A1 (en) Self-tanning composition comprising carmine
WO2001078702A3 (en) Methods and compositions for modulating alpha adrenergic receptor activity
HK1036221A1 (en) Topical composition containing human epidermal growth factor.
CA2406057A1 (en) Methods and compositions for modulating alpha adrenergic receptor activity
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
NZ510254A (en) Novel composition and use
HK1027751A1 (en) Pharmaceutical compositions containing vitamin D and calcium, their preparation and therapeutic use.
WO1999043344A3 (en) Matrix protein compositions for wound healing
NZ504680A (en) Antiperspirant or deodorant compositions containing borage seed oil for topical application
SE9802208D0 (sv) Novel compounds
AU2002212894A1 (en) N-type calcium channel antagonists for the treatment of pain
DE60035059D1 (de) Mittel zur verbesserung der hauttextur
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
HU9602740D0 (en) Halofanthine free base for the treatment of malaria and compositions
EP1133979A3 (de) Verwendung von spezifischen Fettstoffen zur Modifizierung der physico-chemischen Eigenschaften der Haut und/oder der Schleimhaut als Mittel zur Verhinderung oder Reduzierung der Adhäsion von Mikro-organismen darauf
AU9731198A (en) Histogranin peptide and their analgesic use
AU2094200A (en) Cosmetic or medical preparation for topical use
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20180306